Biomaterials from healthcare viewpoint can be defined as “materials those possess some novel properties that makes them appropriate to come in immediate association with the living tissue without eliciting any adverse immune rejection reactions. Biomaterials are in the service of mankind through ancient times but subsequent evolution has made them more versatile and has increased their usage. Biomaterials have transformed the areas like bioengineering and tissue engineering for the development of strategies to counter life threatening diseases. These concepts and technologies are being used for the treatment of different diseases like cardiac failure, fractures, deep skin injuries, etc. Research is being performed to improve the existing methods and for the innovation of new approaches. With the current progress in biomaterials we can expect a future healthcare which will be economically feasible to us. Equipment and consumables was worth US$ 47.7 billion in 2014 and is further expected to reach US$ 55.5 billion in 2020 with a CAGR (2015 to 2020) of 3%.